Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1991

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Type of oral contraceptive in relation to acute, initial episodes of pelvic

inflammatory disease.

AUTHORS

Panser LA; Phipps WR

SOURCE

CONTRACEPTION. 1991 Jan;43(1):91-9.

ABSTRACT

A case-control analysis of hospital-based data was conducted to evaluate whether low-dose combination oral

contraceptives (OCs) protect against pelvic inflammatory disease (PID). Other categories of combination OCs based

on estrogen dose were also assessed. Results indicate that no OC confers protection if taken for <12 months. In

contrast, the education-adjusted relative risk (RR) estimates for continuous exposure of >or= 12 months for various

categories of combination OCs based on estrogen dose all ranged from 0.2-0.4 with overlapping 95% confidence

intervals (CIs): however, the adjusted RR for low-dose pills was not statistically significant (RR=0.4, 95% CI: 0.2,

1.1). These data are consistent with the hypothesis that low-dose estrogen pills as well as higher estrogen OCs

potentially protect against PID requiring hospitalization. Low-dose estrogen combination OCs deserve further study

in relation to PID generally, and more specifically , with regard to specific microorganisms causing PID. (author's)

(PubHealth.info Document ID: CONT3T 2029-06)

PubHealth.info NOTE: The author(s) of this article titled, "Type of oral contraceptive in relation to acute, initial

episodes of pelvic inflammatory disease.", is(are) Panser LA; Phipps WR. The source of this article is

"CONTRACEPTION. 1991 Jan;43(1):91-9.". This article was published in 1991 in English language(s).

(PubHealth.info® Document ID: CONT3T 2029-06. All rights reserved with PubHealth.info) PIN: 12029

This article is peer-reviewed.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.